EEF1A1P39

Across TCGA pan-cancer cohorts, EEF1A1P39 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of EEF1A1P39’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where EEF1A1P39 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EEF1A1P39 is over-expressed in tumor.

KIRC, ESCA, and LUAD are the cancer types where EEF1A1P39 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EEF1A1P39 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.045	.011	3	view →
ESCA	Female	All	+0.246	.004	1	view →
LUAD	All	All	+0.158	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

EEF1A1P39–KIRC

Open the KIRC breakdown →